𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neurotrophic factors for the investigation and treatment of movement disorders

✍ Scribed by Justo Garcia De Yébenes; Marina Sánchez; Maria Angeles Mena

Publisher
Springer-Verlag
Year
2003
Tongue
English
Weight
184 KB
Volume
5
Category
Article
ISSN
1029-8428

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exploiting neurotrophic factors for the
Exploiting neurotrophic factors for the treatment of neurodegenerative conditions: An Australian perspective
✍ Richard A. Hughes; Paul D. O'Leary 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Neurotrophic factors are proteins which promote the growth, survival, and differentiation of neurons. The ability of neurotrophic factors to prevent the degeneration of neurons following nerve lesion and in genetic models of neurodegeneration suggest that they offer therapeutic potential in the trea

Botulinum toxin in the treatment of ling
Botulinum toxin in the treatment of lingual movement disorders
✍ Neema Kasravi; Mandar S. Jog 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract Lingual movement disorders are a rare but serious manifestation of neurologic disease, which have the potential to cause significant morbidity. Traditionally, these disorders were treated with pharmacotherapy achieving only limited results. Several case series have demonstrated the effe

The treatment of psychogenic movement di
The treatment of psychogenic movement disorders with suggestion is ethically justified
✍ Michel C. F. Shamy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract Recent developments in our understanding of psychogenic movement disorders have not yet led to advances in treatment. A potentially beneficial treatment strategy is suggestion, the voluntary use by the physicians of techniques that introduce into the patient's mind a belief that he or s

Long-term tolerability of tetrabenazine
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders
✍ Christopher Kenney; Christine Hunter; Joseph Jankovic 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract We sought to review the long‐term tolerability of tetrabenazine (TBZ) and seek determinants of tolerability in the treatment of hyperkinetic movement disorders. A retrospective chart review was performed on patients treated with TBZ between 1997 and 2004. Efficacy of TBZ was assessed by